The United States Food and Drug Administration (FDA) published Thursday a list of pharmaceutical companies that include Basel-based Novartis and Roche, all of which are suspected of hindering the development of generic versions of their own medicines. Over 150 complaints were filed.
The FDA slammed the development of techniques designed to complicate or even prevent developers of generic drugs from accessing sufficient quantities of original preparations to be able to do comparative studies essential to any application for approval.
The authority said it has received more than 150 complaints over the alleged misuse of FDA programmes or agreements between pharmaceutical companies and distributors.
The FDA noted that it had not investigated these allegations.
SDA-ATS/ds
Related Stories
Popular Stories
More
Global elections
Does democracy really make the world more peaceful?
Thyssenkrupp Presta cuts 570 jobs in Switzerland and Liechtenstein
This content was published on
The group specialising in the production of steering systems for cars, will cut up to 570 jobs in Liechtenstein and the Swiss canton of Appenzell Innerrhoden.
Poll: 63% of Swiss want to vote again on fighter jet procurement
This content was published on
Two out of three Swiss people want to vote again on the purchase of a jet for the air force, according to a representative poll published today by the information portal Infosperber.
Switzerland halts work on futuristic underground freight transport facility
This content was published on
The federal government, the local cantons and the city of Zurich are suspending further work on the Cargo Sous Terrain project for an underground freight transport facility.
Lucerne wants to introduce a flat-rate naturalisation fee
This content was published on
The city council would like to introduce a flat fee of CHF500 per application. This would be significantly lower than the current fee, which is based on the amount of processing required.
Roche claims success against breast cancer in phase III clinical trials
This content was published on
Roche has achieved positive results from the phase III evERA study combining its experimental treatments giredestrant and everolimus against a specific form of breast cancer.
Swiss intelligence not doing enough against left-wing extremism
This content was published on
The Federal Intelligence Service (FIS) is not utilising all the resources available within the legal framework in the fight against left-wing extremist violence.
Anti-mafia crusader Roberto Saviano receives thunderous applause in Switzerland
This content was published on
Roberto Saviano appeared at the Endorfine International Festival. Lugano. Stating that after 20 years of struggle he does not intend to leave victory to the Mafia, the Neapolitan writer drew thunderous applause.
This content was published on
Each year, some half a million people die of malaria, many of them children. Switzerland is a world leader in research to combat the disease.
Swiss authorities allowed isopropanol exports to Syria
This content was published on
Switzerland authorised the export to Syria of the chemical isopropanol in 2014, which can be used to make sarin gas, RTS, reports.
Novartis and GSK CEOs set out diverging strategies
This content was published on
It is a tale of two newly minted chief executives, each looking to send a clear signal to investors about strategy and priorities.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.